TOVALT
Live / Applied — First extension granted (statement of use) (as of 30 Mar 2026)
What this means for you
Not registered yet, but its 03 Dec 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98882592
- Mark type
- Stylized text
- Filed
- 03 Dec 2024
- Published for opposition
- 02 Sept 2025
- Attorney of record
- Joseph I. Hirsch
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the prevention and treatment of disorders, diseases, conditions and ailments of the immune system, cardio-vascular system, respiratory system, musculoskeletal system and central nervous system; pharmaceutical preparations and substances for the prevention and treatment of inflammatory disorders; pharmaceutical preparations and substances for the prevention and treatment of hypertension; pharmaceutical preparations and substances for the prevention and treatment of oncologic and metabolic disorders, diseases, conditions and ailments; pharmaceutical preparations and substances for use in dermatology; pharmaceutical preparations and substances for the treatment of depression, obsessive compulsive disorders, central nervous system movement disorders, spinal cord diseases, encephalitis, epilepsy, cerebral palsy, Parkinson's disease, insomnia, mood disorders, bipolar disorder, seizure disorders, brain injury, spinal cord injury, Alzheimer's disease, Huntington's disease and cerebral palsy; pharmaceutical preparations and substances for the prevention, treatment and alleviation of psychiatric disorders, diseases, conditions and ailments, namely mood disorders, anxiety disorders, panic disorders, bipolar disorder, cognitive disorders, schizophrenia and depression; pain relief medications and analgesics.
Owner
- Newcastle Bioscience, LLC, Naples, FL, US
- Newcastle Bioscience, LLC, Naples, FL, US
Prosecution history
- 02 Apr 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Mar 2026 — SOU EXTENSION 1 GRANTED
- 30 Mar 2026 — SOU EXTENSION 1 FILED
- 30 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 28 Oct 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 02 Sept 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 02 Sept 2025 — PUBLISHED FOR OPPOSITION
- 27 Aug 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 25 Jul 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 22 May 2025 — ASSIGNED TO EXAMINER
- 03 Dec 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 03 Dec 2024 — NEW APPLICATION ENTERED